News

SYDNEY, Australia – 10 November 2022: In time for World Diabetes Day, model Bambi Northwood -Blyth joins Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its Australian subsidiary Australasian Medical and Scientific Ltd (AMSL) Diabetes to announce the arrival of the global Dexcom Warrior program in …

Continue reading "Model Bambi Northwood-Blyth Supports Dexcom Warriors Coming to Australia in 2023"

As of Friday 29th July 2022, AMSL Diabetes will discontinue the sale of Transmitters and Sensors for the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) system. In addition to removing Dexcom G5 Mobile from the NDSS CGM Subsidy Initiative on 1 March 2022, Dexcom G5 Mobile will no longer be available for private purchase via the …

Continue reading "Dexcom G5 Mobile manufactured by Dexcom – Supply Update"

1 August 2022 Update – Streamlined access for self-funded Existing Dexcom G6 Users has now closed as of 31st July 2022. All individuals, whether existing customers or new to Dexcom G6 will need to see their healthcare professional in order to get started with this application process. 1 July 2022 – Dexcom and AMSL Diabetes …

Continue reading "Government launches subsidised Continuous Glucose Monitoring for all Australians living with type 1 diabetes from 1 July 2022"

21 April 2022 – Dexcom and AMSL Diabetes welcome the recent bi-partisan commitment to providing access to continuous glucose monitoring for all people with Type 1 diabetes in Australia. Expanding the subsidy access to all people with Type 1 diabetes in Australia irrespective of their age and concession card status is an important reform that improves …

Continue reading "Government pledges additional Continuous Glucose Monitoring Subsidies for all Australians living with type 1 diabetes"

April 2022 – AMSL Diabetes is excited to announce the launch of Control-IQ™ technology for the t:slim X2™ insulin pump! The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within Australia; Control-IQ. Control-IQ technology is an advanced hybrid …

Continue reading "Control-IQ Technology for the t:slim X2 Insulin Pump Launches in Australia"

Advanced features not available on any other device Government paves the way for improved access to game-changing technology for eligible Australians living with Type 1 diabetes Sydney, 8 February 2022 – AMSL Diabetes has today announced that the Dexcom G6 Continuous Glucose Monitoring (CGM) system will be available through the Australian Government’s CGM Subsidy Initiative …

Continue reading "National Diabetes Services Scheme (NDSS) fully subsidises the most advanced Dexcom Continuous Glucose Monitoring (CGM) technology"

January 2022 We would like to advise that we have been notified that our delivery couriers are experiencing some delays due to the ongoing COVID-19 crisis. We are continuing to process all orders and thank you for your patience. To help keep our phone lines available for urgent enquiries, if you would like an update …

Continue reading "Courier Shipping Delays may occur due to COVID-19"